46
Views
9
CrossRef citations to date
0
Altmetric
Original Research

1,3-Bis(2-chloroethyl)-1-nitrosourea-loaded bovine serum albumin nanoparticles with dual magnetic resonance–fluorescence imaging for tracking of chemotherapeutic agents

, , , , , & show all
Pages 4065-4075 | Published online: 23 Aug 2016

References

  • WenPYKesariSEnglNMalignant gliomas in adultsN Engl J Med200835949250718669428
  • Gloeckler RiesLAReichmanMELewisDRHankeyBFEdwardsBKCancer survival and incidence from the surveillance, epidemiology, and end results (SEER) programOncologist2003854155214657533
  • RhinesLDSampathPDolanMETylerBMBremHWeingartJO6-benzylguanine potentiates the antitumor effect of locally delivered carmustine against an intracranial rat gliomaCancer Res2000606307631011103789
  • LucienneJJThe targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?Drug Discov Today20081323–241099110618848640
  • AndersenCTaagehøjJFMühlerARehlingMApproximation of arterial input curve data in MRI estimation of cerebral blood-tumor-barrier leakage: comparison between Gd-DTPA and 99mTc-DTPA input curvesMagn Reson Imaging19961432352418725189
  • BlackKLNingarajNSModulation of brain tumor capillaries for enhanced drug delivery selectively to brain tumorCancer Control200411316517315153840
  • HynynenKMcDannoldNSheikovNALocal and reversible blood–brain barrier disruption by noninvasive focused ultrasound at frequencies suitable for trans-skull sonicationsNeuroimage200524122015588592
  • LiuHLHuaMYYangHWMagnetic resonance monitoring of focused ultrasound/magnetic nanoparticle targeting delivery of therapeutic agents to the brainProc Natl Acad Sci U S A201010734152051521020696897
  • FanCHTingCYLinHJSPIO-conjugated, doxorubicin-loaded microbubbles for concurrent MRI and focused-ultrasound enhanced brain-tumor drug deliveryBiomaterials201334143706371523433776
  • ChaeGSLeeJSKimSHEnhancement of the stability of BCNU using self-emulsifying drug delivery systems (SEDDS) and in vitro antitumor activity of self-emulsified BCNU-loaded PLGA waferInt J Pharm20053011–261416024190
  • YangHWHuangCYLinCWGadolinium-functionalized nanographene oxide for combined drug and microRNA delivery and magnetic resonance imagingBiomaterials201435246534654224811259
  • KimGYTylerBMTupperMMResorbable polymer microchips releasing BCNU inhibit tumor growth in the rat 9L flank modelJ Control Release2007123217217817884232
  • ZhongZWanYShiSHanJZhangZSunXMaterials innovation for co-delivery of diverse therapeutic cargosPharm Res201229114515721789727
  • YangHWLuYJLinKJEGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapyBiomaterials201334297204721423800742
  • TemmingKMeyerDLZabinskiRImproved efficacy alpha(v) beta(6)-targeted albumin conjugates by conjugation of a novel auristatin derivativeMol Pharm2007468669417683157
  • IyerAKKhaledGFangJMaedaHExploiting the enhanced permeability and retention effect for tumor targetingDrug Discov200611812818
  • BattogtokhGKangJHKoYTLong-circulating self-assembled cholesteryl albumin nanoparticles enhance tumor accumlation of hydrophobic acticancer drugEur J Pharm Biopharm2015969610526212785
  • FelixKAlbumin as a drug carrier: design of prodrugs, drug conjugates and nanoparticlesJ Control Release2008132317118318582981
  • BartlingSHBudjanJAvivHFirst multimodal embolization particles visible on X-ray/computed tomography and magnetic resonance imagingInvest Radiol201146317818621263332
  • HagitASoenkeBJohannesBShlomoMSynthesis and characterization of dual modality (CT/MRI) core-shell microparticles for embolization purposesBiomacromolecules2010111600160720443579
  • OlsonESJiangTAguileraTAActivatable cell penetrating peptides linked to nanoparticles as dual probes for in vivo fluorescence and MR imaging of proteasesProc Natl Acad Sci U S A201010794311431620160077
  • CaiWChenKLiZBGambhirSSChenXDual-function probe for PET and near-infrared fluorescence imaging of tumor vasculatureNucl Med20074818621870
  • LiuZLammersTEhlingJIron oxide nanoparticle-containing microbubble composites as contrast agents for MR and ultrasound dual-modality imagingBiomaterials201132266155616321632103
  • AntochGKuehlHKanjaJDual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluationRadiology2004230387988514764889
  • ZhangMYilmazTBoztasAOA multifunctional nanoparticulate theranostic system with simultaneous chemotherapeutic, photothermal therapeutic, and MRI contrast capabilitiesRSC Adv201662779827806
  • JiSXuJZhangBRGD-conjugated albumin nanoparticles as a novel delivery vehicle in pancreatic cancer therapyCancer Biol Ther201213420621522354009
  • YangHWHuaMYLiuHLSelf-protecting core-shell magnetic nanoparticles for targeted, traceable, long half-life delivery of BCNU to gliomasBiomaterials201132276523653221645920
  • SripriyalakshmiSAnjaliCHGeorge Priya DossCBSA nanoparticle loaded atorvastatin calcium – a new facet for an old drugPLoS One20149e8631724498272
  • SadeghiRMoosavi-MovahediAAEmam-jomehZThe effect of different desolvating agents on BSA nanoparticle properties and encapsulation of curcuminJ Nanopart Res2014162565
  • HuaMYLiuHLYangHWThe effectiveness of a magnetic nanoparticle-based delivery system for BCNU in the treatment of gliomasBiomaterials201132251652721030073
  • KapoorDNManviFVDoijadRCDhawanSPrednisolone-loaded albumin nanospheres: in vitro and in vivo evaluation studiesPDA J Pharm Sci Technol20086211112418540537
  • ChenFXBodellWJLiangGReaction of N-(2-chloroethyl)-N-nitrosoureas with DNA: effect of buffers on DNA adduction, cross-linking, and cytotoxicityChem Res Toxicol199692082148924592